130 related articles for article (PubMed ID: 36389209)
1. Nucleotide and nucleoside-based drugs: past, present, and future.
Abdullah Al Awadh A
Saudi J Biol Sci; 2022 Dec; 29(12):103481. PubMed ID: 36389209
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow.
Goswami D
RSC Adv; 2021 Aug; 11(46):29015-29028. PubMed ID: 35478553
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase.
Chien M; Anderson TK; Jockusch S; Tao C; Kumar S; Li X; Russo JJ; Kirchdoerfer RN; Ju J
bioRxiv; 2020 Mar; ():. PubMed ID: 32511320
[TBL] [Abstract][Full Text] [Related]
4. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
5. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System.
Min JS; Kwon S; Jin YH
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440200
[TBL] [Abstract][Full Text] [Related]
7. Incorporation efficiency and inhibition mechanism of 2'-substituted nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase.
Yuan C; Goonetilleke EC; Unarta IC; Huang X
Phys Chem Chem Phys; 2021 Sep; 23(36):20117-20128. PubMed ID: 34514487
[TBL] [Abstract][Full Text] [Related]
8. Identifying Structural Features of Nucleotide Analogues to Overcome SARS-CoV-2 Exonuclease Activity.
Wang X; Tao C; Morozova I; Kalachikov S; Li X; Kumar S; Russo JJ; Ju J
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891393
[TBL] [Abstract][Full Text] [Related]
9. Broad-spectrum non-nucleoside inhibitors for caliciviruses.
Netzler NE; Enosi Tuipulotu D; Eltahla AA; Lun JH; Ferla S; Brancale A; Urakova N; Frese M; Strive T; Mackenzie JM; White PA
Antiviral Res; 2017 Oct; 146():65-75. PubMed ID: 28757394
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Viral RNA-Dependent RNA Polymerases by Nucleoside Inhibitors: An Illustration of the Unity and Diversity of Mechanisms.
Barik S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293509
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of inhibition of viral RNA replication by nucleotide analogs.
Johnson KA; Dangerfield T
Enzymes; 2021; 49():39-62. PubMed ID: 34696838
[TBL] [Abstract][Full Text] [Related]
12. Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients.
García-Trejo JJ; Ortega R; Zarco-Zavala M
Front Oncol; 2021; 11():664794. PubMed ID: 34367956
[TBL] [Abstract][Full Text] [Related]
13. Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase.
Li Q; Yi D; Lei X; Zhao J; Zhang Y; Cui X; Xiao X; Jiao T; Dong X; Zhao X; Zeng H; Liang C; Ren L; Guo F; Li X; Wang J; Cen S
Acta Pharm Sin B; 2021 Jun; 11(6):1555-1567. PubMed ID: 33614402
[TBL] [Abstract][Full Text] [Related]
14. Novel guanosine derivatives against MERS CoV polymerase: An
Elfiky AA; Azzam EB
J Biomol Struct Dyn; 2021 May; 39(8):2923-2931. PubMed ID: 32306854
[TBL] [Abstract][Full Text] [Related]
15. HCV RdRp, sofosbuvir and beyond.
Feng JY; Ray AS
Enzymes; 2021; 49():63-82. PubMed ID: 34696839
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside Inhibitors of Coronaviruses.
Zenchenko AA; Drenichev MS; Mikhailov SN
Curr Med Chem; 2021; 28(26):5284-5310. PubMed ID: 33563148
[TBL] [Abstract][Full Text] [Related]
17. Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease.
Rabie AM
ACS Omega; 2022 Jun; 7(25):21385-21396. PubMed ID: 35785294
[TBL] [Abstract][Full Text] [Related]
18. Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp.
Zhao J; Zhang Y; Wang M; Liu Q; Lei X; Wu M; Guo S; Yi D; Li Q; Ma L; Liu Z; Guo F; Wang J; Li X; Wang Y; Cen S
ACS Infect Dis; 2021 Jun; 7(6):1535-1544. PubMed ID: 34038639
[TBL] [Abstract][Full Text] [Related]
19. Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections.
Huchting J
Antivir Chem Chemother; 2020; 28():2040206620976786. PubMed ID: 33297724
[TBL] [Abstract][Full Text] [Related]
20. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.
Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM
Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
